Method for determining therapeutic drug dosage using bioelectrical resistance and reactance measurements

• US 4,880,014 A
• Filed: 02/26/1988
• Issued: 11/14/1989
• Est. Priority Date: 08/14/1987
• Status: Expired due to Fees

• Current Assignee: BIDD Incorporated
• Original Assignee: BIDD Incorporated
• Inventors: Twyman, Diana L., Zarowitz, Barbara J.
• Primary Examiner(s): Jaworski, Francis
• Assistant Examiner(s): Manuel, George
• Application Number:
  US07/160,589
• Time in Patent Office: 627 Days
• Field of Search: 128/693, 604/734, 604/50, 364/413.07, 364/413.11, 364/413.1
• US Class Current: 600/547
• CPC Class Codes: A61B 5/00 Measuring for diagnostic purposes radiation diagnosis A61B6/00; diagnosis by ultrasonic, sonic or infrasonic waves A61B8/00; Identification of persons
• CPC Class Codes: A61B 5/0537 Measuring body composition by impedance, e.g. tissue hydration or fat content
• CPC Class Codes: A61B 5/4869 Determining body composition

Abstract

A method for determining a dosage regimen for a drug. Resistance (R) and reactance (Xc) are measured by bioelectrical impedance analysis with an impedance plethysmograph. Personal characteristics of a subject are ascertained and recorded along with the measured values of R and Xc. A technique for generating equations which relate the measured values of R and Xc and selected personal characteristics to pharmacokinetic parameters such as volume of distribution (V), elimination rate constant (K), and clearance (CL) for a particular drug are provided. These equations are used with the measured values of R and Xc and certain personal characteristics to determine predictive values for the desired pharmacokinetic parameters. These predictive values are then used to determine an appropriate drug dosage regimen for the patient.

Claims

1. A method for determining a therapeutic drug dosage regimen for a biological subject which comprises the steps of:

providing a first equation which relates at least one of the following personal characteristics, resistance, reactance, age, height, weight and sex of the subject, to a predictive value for volume of distribution (V) for a preselected drug in said subject;

providing a second equation which relates at least one of the following personal characteristics, resistance, reactance, age, height, weight and sex of said subject, to a predictive value for elimination rate constant (K) for said preselected drug in said subject;

determining the value of said personal characteristics of said subject which are related to said first equation for the predictive value for V;

determining the value of said personal characteristics of said subject which are related to said second equation for the predictive value for K;

calculating said predictive value of V using said first equation and said value of said measured personal characteristics related to said first equation;

calculating said predictive value of K using said second equation and said value of said measured personal characteristics related to said second equation;

determining a desired therapeutic concentration of said preselected drug for said subject; and

calculating a dose and dosing interval to obtain said therapeutic concentrations of said drug using said calculated predictive values of V and K.

2. The method for determining a therapeutic drug dosage regimen for a biological subject recited in claim 1, further including the steps of:

providing a third equation which relates at least one of the following personal characteristics, resistance, reactance, age, height, weight and sex of said subject, to a predictive value for clearance (CL) for said drug in said subject;

determining the value of said personal characteristics of said subject which are related to said third equation for the predictive value for CL;

calculating said predictive value of CL using said third equation and said value of said measured personal characteristics related to said third equation; and

using said calculated predictive value of CL in said dose and dosing interval calculating step in addition to said calculated predictive values of V and K.

3. The method for determining a therapeutic drug dosage regimen recited in claim 1, wherein said steps of determining the value of said personal characteristics related to said first equation and determining the value of said personal characteristics related to said second equation include the steps of attaching at least one current electrode and at least one detector electrode to said subject, said current electrode and said detector electrode being in electrical communication with an impedance plethysmograph;

flowing an excitation current through a portion of said subject'"'"'s body with said impedance plethysmograph and said current electrode;

detecting the voltage drop of said current with said detector electrode and said impedance plethysmograph; and

determining said resistance and said reactance from said voltage drop with said impedance plethysmograph.

4. A method for determining a therapeutic drug dosage regiment for a biological subject comprising the steps of:

generating equations which relate resistance (R) and reactance (Xc) to volume of distribution (V) and elimination rate constant (K) for a preselected drug

measuring the resistance (R) and reactance (Xc) of a subject by bioelectric impedance analysis;

solving said equations for V and K by utilizing said measured values of R and Xc;

determining a dosage regiment for said subject for said preselected drug by utilizing the values of V and K determined in said equation solving step.

5. The method for determining a therapeutic drug dosage regiment for a biological subject recited in claim 4, wherein said generating step includes analyzing preselected independent variables, including said resistance (R) and reactance (Xc) by a linear regression method.

6. The method for determining a therapeutic drug dosage regiment for a biological subject recited in claim 4, further including the steps of generating an equation which relates said resistance (R) and reactance (Xc) to clearance (CL), solving said equation for CL and utilizing said value of CL obtained in said CL equation solving step in said dosage determining step.

7. The method for determining a therapeutic drug dosage regimen for a biological subject recited in claim 6, wherein said step of attaching said current electrode and said detector includes attaching said current electrode and said detector electrode ipsilaterally on said subject.

8. The method for determining a therapeutic drug dosage regimen for a biological subject recited in claim 6, wherein said flowing step includes flowing a current of about 800 microamps and from about 100 Hz to 1 MHz through said subject'"'"'s body.

9. The method for determining a therapeutic drug dosage regimen for a biological subjected recited in claim 6, wherein said generating steps include analyzing preselected independent variables, including said resistance (R) and reactance (Xc) by a linear regression method.

10. A method for calculating a drug dosage regimen for a human subject comprising the steps of measuring the values of resistance (R) and reactance (Xc) for a human subject and determining a drug dosage regimen for a preselected drug for said human subject by utilizing said measured values of said resistance (R) and reactance (Xc).

11. A non-invasive method for determining the drug dose and dosing interval for a given drug to produce a preselected therapeutic concentration profile of a drug in a subject comprising the steps of determining the age, sex, weight, and height of the subject;

measuring the bioelectrical impedance of the subject using a bioelectrical impedance plethysmograph;

determining the resistance and reactance components of said measured bioelectrical impedance;

determining the volume of distribution and elimination rate constant characteristics of said drug;

selecting said therapeutic concentration profile to be produced in the subject;

determining said volume of distribution value and said elimination rate constant value for the subject patient using said measured values of resistance and reactance and said values for said subject'"'"'s age, sex, height, and weight for said drug; and

calculating said dose and said dosing interval for said drug for the subject to produce said preselected therapeutic drug concentration profile based on said determined values of said volume of distribution and said elimination rate constant.